Berko Pharmaceuticals, a strong brand in the Turkish pharmaceutical market and a pioneer in achieving “For Healthy Tomorrows”, took another important step towards becoming a world brand and received EU GMP (Good Manufacturing Practices) Certificate, and thus, it has made an important step towards becoming more effective in global markets with its high quality production standard.
Berko Pharmaceuticals, which will enter its 40th year next year, is entering its 40th year stronger with the EU GMP Certificate. Berko Pharmaceuticals, which applied to the Bulgarian Pharmaceuticals Authority (BDA) and successfully completed the inspection processes at its production facilities in Sultanbeyli, Istanbul, received the European GMP Certificate.
Exporting to 23 countries, Berko Pharmaceuticals’ EU-GMP certificate provides trade opportunities with European Union countries, as well as a reference value for entry to all other regulated markets. Berko Pharmaceuticals will increase its export volume and provide prestige and price advantage in the global market with the EU GMP Certificate it has applied for in order to license drugs and export drugs in European Union countries.
Berko Pharmaceuticals, which makes high quality production with original product formulations and shapes, will now be able to export to more countries with EU GMP certificate. Berko Pharmaceuticals R&D Center, on the other hand, will continue its R&D activities not only for the Turkish market, but also for the European market, with its laboratories and infrastructure facilities that allow the research of advanced technological products and the development of innovative products.
Pharm. Barış Özyurtlu, General Manager, Berko Pharmaceuticals, on the subject, said, “With this audit process, our company has proven once again that it can develop and license generic products for the European Union and other regulated markets and produce products with the latest GMP requirements and high level pharmaceutical quality standards. We will now bring our products, which reflect our innovative approach and innovative vision, to the European Union countries, with our EU-GMP-owned production facilities and our Foreign Regulatory team experienced in the global market. As a domestic manufacturer with the increase in our export capacity, we are proud of making an additional contribution to the country’s economy. I wish the best for both our company and our country. I would like to thank all our company managers and employees who contributed to the application and audit processes, especially our Chairman of the Board of Directors Berat Beran.”
